Page last updated: 2024-08-23

raloxifene hydrochloride and Carcinogenesis

raloxifene hydrochloride has been researched along with Carcinogenesis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, KM; Rosengren, RJ; Scandlyn, MJ; Taurin, S	1
Biddick, L; Brewer, M; Bryant, T; Gali, H; Janakiram, NB; Lightfoot, S; Mohammed, A; Pathuri, G; Rao, CV	1

Other Studies

2 other study(ies) available for raloxifene hydrochloride and Carcinogenesis

Article	Year
Raloxifene reduces triple-negative breast cancer tumor growth and decreases EGFR expression. International journal of oncology, 2013, Volume: 43, Issue:3 Topics: Animals; Apoptosis; Carcinogenesis; Cell Movement; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Invasiveness; Raloxifene Hydrochloride; Receptors, Estrogen; Triple Negative Breast Neoplasms	2013
Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells. Cancer prevention research (Philadelphia, Pa.), 2014, Volume: 7, Issue:3 Topics: Adenomatous Polyposis Coli Protein; Animals; Carcinogenesis; Cell Count; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Hematopoietic Stem Cells; Immunity, Cellular; Intestinal Neoplasms; Intestines; Killer Cells, Natural; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2014

Article

Year

Raloxifene reduces triple-negative breast cancer tumor growth and decreases EGFR expression.

International journal of oncology, 2013, Volume: 43, Issue:3

Topics: Animals; Apoptosis; Carcinogenesis; Cell Movement; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Invasiveness; Raloxifene Hydrochloride; Receptors, Estrogen; Triple Negative Breast Neoplasms

2013

Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.

Cancer prevention research (Philadelphia, Pa.), 2014, Volume: 7, Issue:3

Topics: Adenomatous Polyposis Coli Protein; Animals; Carcinogenesis; Cell Count; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Hematopoietic Stem Cells; Immunity, Cellular; Intestinal Neoplasms; Intestines; Killer Cells, Natural; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators

2014